Ignorer les liens de navigation
Qui sommes nous ? Référence-Recherche Pôle Formation Formation universitaire Formation continue E-Formation Formation en partenariat DPC Documentation & publications Service QRE Sang & Transfusion sanguine Europe & International
 
 


Votre recherche : [La BTT] AUTEUR égal Johansson PI
18 résultat(s)


 
BTT Jans O, Kehlet H, Hussain Z, Johansson PI. Transfusion practice in hip arthroplasty--a nationwide study. Vox Sang. 2011;100:374-380.
Thèmes : Transfusion homologue ; maj-2011-11

BTT Levi M, Fries D, Gombotz H, Van der Linden P, Nascimento B, Callum JL, Belisle S, Rizoli S, Hardy JF, Johansson PI, Samama CM, Grottke O, Rossaint R, Henny CP, Goslings JC, Theusinger OM, Spahn DR, Ganter MT, Hess JR, Dutton RP, Scalea TM, Levy JH, Spinella PC, Panzer S, Reesink HW. Prevention and treatment of coagulopathy in patients receiving massive transfusions. Vox Sang. 2011;101:154-174.
Thèmes : Plasma et dérivés plasmatiques ; Transfusion homologue ; maj-2012-02
Notice PubMed

BTT Meyer MA, Ostrowski SR, Windelov NA, Johansson PI. Fibrinogen concentrates for bleeding trauma patients: what is the evidence? Vox Sang. 2011;101:185-190.
Thèmes : Plasma et dérivés plasmatiques ; Transfusion homologue ; maj-2012-02
Notice PubMed

BTT Ostrowski SR, Bochsen L, Windelov NA, Salado-Jimena JA, Reynaerts I, Goodrich RP, Johansson PI. Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology. Transfusion. 2011;51:344-356.
Thèmes : Produits sanguins plaquettaires ; Inactivation des pathogènes ; maj-2011-11

BTT Johansson PI, Stensballe J. Hemostatic resuscitation for massive bleeding: the paradigm of plasma and platelets--a review of the current literature. Transfusion. 2010;50:701-710.
Thèmes : Plasma et dérivés plasmatiques ; Transfusion homologue ; Produits sanguins plaquettaires ; maj-2010-09

BTT Johansson PI. Hemostatic strategies for minimizing mortality in surgery with major blood loss. Curr Opin Hematol. 2009;16:509-514.
Thèmes : Transfusion homologue ; maj-2010-04

BTT Johansson PI, Stensballe J. Effect of Haemostatic Control Resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang. 2009;96:111-118.
Thèmes : Transfusion homologue ; maj-2009-04

BTT Svendsen MS, Kristensen AT, Bochsen L, Salado-Jimena JA, Johansson PI. The in vitro effect of recombinant factor VIIa on coated platelet formation and clot dynamics of stored platelet concentrates. Transfusion. 2009;49:2186-2194.
Thèmes : Thérapeutiques de substitution - Facteurs de croissance ; Biologie vasculaire ; Produits sanguins plaquettaires ; maj-2010-04

BTT Johansson PI, Bochsen L, Andersen S, Viuff D. Investigation of the effect of kaolin and tissue factor-activated citrated whole blood, on clot forming variables, as evaluated by thromboelastography. Transfusion. 2008;48:2377-2383.
Thèmes : Hémostase ; maj-2009-01

BTT Johansson PI, Bochsen L, Stensballe J, Secher NH. Transfusion packages for massively bleeding patients: the effect on clot formation and stability as evaluated by Thrombelastograph (TEG). Transfus Apher Sci. 2008;39:3-8.
Thèmes : Hémostase ; Transfusion homologue ; maj-2009-01

BTT Johansson PI, Svendsen MS, Salado J, Bochsen L, Kristensen AT. Investigation of the thrombin-generating capacity, evaluated by thrombogram, and clot formation evaluated by thrombelastography of platelets stored in the blood bank for up to 7 days. Vox Sang. 2008;94:113-118.
Thèmes : Produits sanguins plaquettaires ; maj-2008-04

BTT Johansson PI. Off-label use of recombinant factor VIIa for treatment of haemorrhage : results from randomized clinical trials. Vox Sang. 2008;95:1-7.
Thèmes : Plasma et dérivés plasmatiques ; Thérapeutiques de substitution - Facteurs de croissance ; maj-2008-08

BTT Kirkeby A, Torup L, Bochsen L, Kjalke M, Abel K, Theilgaard-Monch K, Johansson PI, Bjorn SE, Gerwien J, Leist M. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO). Thromb Haemost. 2008;99:720-728.
Thèmes : Thérapeutiques de substitution - Facteurs de croissance ; maj-2008-08

BTT Johansson PI, Stensballe J, Rosenberg I, Hilslov TL, Jorgensen L, Secher NH. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion. 2007;47:593-598.
Thèmes : Transfusion homologue

BTT Johansson PI. The blood bank: from provider to partner in treatment of massively bleeding patients. Transfusion. 2007;47:176S-181S.
Thèmes : Transfusion homologue ; Aspects réglementaires et management en transfusion ; Activités de Préparation Qualification et Distribution ; maj-2008-01

BTT Svendsen MS, Rojkjaer R, Kristensen AT, Salado-Jimena JA, Kjalke M, Johansson PI. Impairment of the hemostatic potential of platelets during storage as evaluated by flow cytometry, thrombin generation, and thrombelastography under conditions promoting formation of coated platelets. Transfusion. 2007;47:2057-2065.
Thèmes : Activités de Préparation Qualification et Distribution ; Produits sanguins plaquettaires ; maj-2008-01

BTT Simonsen AC, Johansson PI, Conlan MG, Jacquet M, Lin JS, Junge K, Lin L, Sorensen H, Borregaard N, Flament J. Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study. Transfusion. 2006;46:424-433.
Thèmes : Inactivation des pathogènes ; maj-2006-06

BTT Johansson PI, Hansen MB, Sorensen H. Transfusion practice in massively bleeding patients: time for a change? Vox Sang. 2005;89:92-96.
Thèmes : Transfusion homologue ; maj-2005-10